Implied Macular Degeneration, BPH Claims Subject Of “Courtesy” Letters
This article was originally published in The Tan Sheet
Executive Summary
Claims for Rexall's Vuemax Intensive suggest the eye-health supplement is intended to "treat, prevent or mitigate" macular degeneration, a July 30 FDA "courtesy" letter to the firm states